AstraZeneca CEO says participant had neurological symptoms, could be discharged today

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says

By ADAM FEUERSTEIN

WIN MCNAMEE/GETTY IMAGES

AstraZeneca's CEO said in a private call with investors that the participant had symptoms consistent with a rare spinal inflammatory disorder.

READ MORE